newsfilter
← Latest News
PR Newswire·

Lipocine Announces Filing of New Drug Submission for TLANDO® in Canada

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to enable effective oral delivery of...